Schrödinger, Inc.

NASDAQ:SDGR

Medical - Healthcare Information Services

Healthcare
$27.20 +0.01%

+$0.00 today

Market cap
$1.79B
Beta
1.64
P/E (TTM)
-11.1
EPS (TTM)
-$1.40
52W Low $10.95High $23.75

Volume 1.18M

Average 1.35M

SDGR Interest Income

Income earned on cash, deposits, and investments held by the company.

Schrödinger, Inc.NASDAQ: SDGR

Interest Income · Q3 FY2026 · quarter ended Sep 2026

Interest income remains negative

Q3 FY2026 interest income was $0, compared with $0 a year earlier. Trailing-twelve-month interest income was $0.

Context

  • Interest income amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Interest income increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly interest income holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMSep 2026
$0— YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Interest Income history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Interest Income vs competitors

How SDGR compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest income is compared through growth and share of revenue rather than absolute size.
  • Interest income amounts to 0.0% of revenue for SDGR, versus a peer median of 1.2%.
SDGR Competitors
Interest Income for SDGR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RLAYRelay Therapeutics, Inc.LTM Jun 2026$24.58M USD-23.6%+45.4%237.5%
GENBGenerate Biomedicines, Inc.FY2025$13.66M USD-24.6%—42.8%
ABCLAbCellera Biologics Inc.LTM Sep 2026$9.56M USD-69.2%+20.8%14.1%
SLPSimulations Plus, Inc.LTM Feb 2026$964K USD-52.9%+0.2%1.2%
LTRNLantern Pharma Inc.LTM Mar 2026$330.3K USD-52.2%+28.9%—
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$40K CAD——0.2%
SDGRSchrödinger, Inc.LTM Sep 2026$0 USD——0.0%
VEEVVeeva Systems Inc.LTM Jul 2026$0 USD——0.0%
CERTCertara, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding SDGR) —-52.2%+24.9%1.2%

Competitors are the stored peer set for SDGR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue137.93M180.96M216.67M207.54M255.87M
Cost of Revenue72.31M79.93M75.97M75.46M113.26M
Gross Profit65.62M101.02M140.69M132.08M142.61M
Gross Margin47.6%55.8%64.9%63.6%55.7%
Research & Development90.9M126.37M181.77M201.79M173.14M
Selling, General & Admin86.16M121.47M136.37M139.59M136.37M
Operating Expenses177.06M247.84M318.14M341.38M309.51M
Depreciation & Amortization2.85M4.34M5.55M6.16M6.02M
EBITDA(97.96M)(144.78M)48.47M(179.55M)(96.3M)
EBITDA Margin-71.0%-80.0%22.4%-86.5%-37.6%
Operating Income(111.44M)(146.82M)(177.45M)(209.3M)(166.9M)
Operating Margin-80.8%-81.1%-81.9%-100.8%-65.2%
Interest Income1.06M3.95M000
Interest Expense03K000
Other Income / Expenses10.64M(2.31M)220.37M23.59M64.57M
Income Before Tax(100.81M)(149.12M)42.92M(185.71M)(102.33M)
Pre-Tax Margin-73.1%-82.4%19.8%-89.5%-40.0%
Income Tax Expense411K63K2.2M1.41M939K
Net Income(100.39M)(149.19M)40.72M(187.12M)(103.27M)
Net Margin-72.8%-82.4%18.8%-90.2%-40.4%
EPS (Basic)(1.43)(2.10)0.57(2.57)(1.41)
EPS (Diluted)(1.43)(2.10)0.54(2.57)(1.41)
Weighted Avg Shares70.59M71.17M71.78M72.67M73.44M
Weighted Avg Shares (Diluted)70.59M71.17M74.99M72.67M73.44M

Schrödinger, Inc.

NASDAQ:SDGR

Intrinsic Alpha fair value

Locked

Current Price

$27.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.